|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006613,
umls-concept:C0013216,
umls-concept:C0032790,
umls-concept:C0034897,
umls-concept:C0038952,
umls-concept:C0205284,
umls-concept:C0205420,
umls-concept:C0441889,
umls-concept:C0449438,
umls-concept:C0449774,
umls-concept:C0728940,
umls-concept:C0854778,
umls-concept:C1522449
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-10-7
|
|
pubmed:abstractText |
To analyze the impact of surgical margins and other clinicopathological data on treatment outcomes on 75 patients treated from 1999 to 2006 by initial potentially curative surgery (+/- intraoperative radiotherapy), followed by high-dose 3-dimensional conformal radiation therapy and concomitant fluoropyrimidine-based chemoradiotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
pubmed-author:GibbonsJosephJ,
pubmed-author:HardacreJeffrey MJM,
pubmed-author:HarppDeborahD,
pubmed-author:KinsellaTimothy JTJ,
pubmed-author:SanabriaJuan RJR,
pubmed-author:SchulakJames PJP,
pubmed-author:SeoYujiY,
pubmed-author:SiegelChristopher TCT,
pubmed-author:StellatoThomas ATA,
pubmed-author:WillisJosephJ,
pubmed-author:WillsonJames KJK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
446-53
|
|
pubmed:dateRevised |
2010-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18838880-Adenocarcinoma,
pubmed-meshheading:18838880-Adult,
pubmed-meshheading:18838880-Aged,
pubmed-meshheading:18838880-Aged, 80 and over,
pubmed-meshheading:18838880-Antineoplastic Agents,
pubmed-meshheading:18838880-CA-19-9 Antigen,
pubmed-meshheading:18838880-Combined Modality Therapy,
pubmed-meshheading:18838880-Female,
pubmed-meshheading:18838880-Fluorouracil,
pubmed-meshheading:18838880-Follow-Up Studies,
pubmed-meshheading:18838880-Humans,
pubmed-meshheading:18838880-Lymphatic Metastasis,
pubmed-meshheading:18838880-Male,
pubmed-meshheading:18838880-Middle Aged,
pubmed-meshheading:18838880-Neoplasm Recurrence, Local,
pubmed-meshheading:18838880-Neoplasm Staging,
pubmed-meshheading:18838880-Pancreatectomy,
pubmed-meshheading:18838880-Pancreatic Neoplasms,
pubmed-meshheading:18838880-Pancreaticoduodenectomy,
pubmed-meshheading:18838880-Postoperative Period,
pubmed-meshheading:18838880-Prognosis,
pubmed-meshheading:18838880-Radiotherapy Dosage,
pubmed-meshheading:18838880-Survival Rate,
pubmed-meshheading:18838880-Tomography, X-Ray Computed
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106-6068, USA. timothy.kinsella@uhhospitals.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
